World’s 1st Total Knee Replacement Patient Treated with PolarisAR Breakthrough Mixed-Reality Surgical Guidance System

STELLAR Knee ushers in a new era of mixed-reality total joint arthroplasty

PolarisAR

PolarisAR, a developer of advanced mixed-reality surgical guidance technology, announced the first total knee arthroplasty (TKA) using its STELLAR Knee mixed-reality surgical guidance system.

The procedure was performed at New York-Presbyterian/Columbia University Irving Medical Center in New York.

STELLAR Knee

STELLAR Knee is a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment. The mixed-reality system acts as a spatial computer, creating continuous data exchange between the surgeon and the software to help enhance surgical decision-making while simplifying operating room workflow.

Paul Mikus, CEO of PolarisAR

“STELLAR Knee represents a paradigm shift in the OR, as we aim to offer surgeons robot-like precision and real-time guidance throughout TKA procedures. STELLAR Knee also fills a crucial gap in hospitals where existing robotic systems may already be in use. By seamlessly integrating into surgical workflows and delivering comparable precision in a mixed reality format, STELLAR Knee ensures that every patient can now access the highest standard of care.”

FDA

The U.S. Food & Drug Administration (FDA) cleared the STELLAR Knee mixed-reality surgical guidance system in November 2023 for use in TKA procedures.

The STELLAR Knee system is designed to offer precise control over intraoperative variables compared to traditional instruments, navigation systems, and first-generation augmented reality. Through meticulous measurement, planning and guidance, it enables surgeons to optimize lower limb alignment, soft tissue balance, joint line maintenance and component positioning.

Over the next coming several weeks, STELLAR Knee’s commercial launch will continue at leading institutions throughout the U.S.

Traditional Techniques for TKA

Traditional techniques for TKA have long been associated with various challenges and limitations. Surgeons often face difficulties in achieving precise alignment and balance of the lower limb. Additionally, closed implant systems and preoperative imaging methods may restrict flexibility and customization, limiting the surgeon’s ability to tailor the procedure to individual patient needs. In addition, traditional robotic technologies, with their large intraoperative footprint, can present barriers to widespread adoption. By contrast, Stellar Knee is agnostic to implant and imageless, making it more accessible to surgeons. The democratization of enabling technologies is a key objective for PolarisAR.

SourcePolarisAR

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”